DNB Asset Management AS Boosts Globus Medical Stake by 51%

The investment firm increased its holding in the medical device company during the third quarter.

Mar. 3, 2026 at 12:47am

Got story updates? Submit your updates here. ›

DNB Asset Management AS, an investment firm, increased its stake in Globus Medical, Inc. (NYSE:GMED) by 51.1% during the third quarter of 2026. The firm now owns 200,918 shares of the medical device company's stock, worth approximately $11.5 million.

Why it matters

Globus Medical is a leading manufacturer of spinal implants and surgical instruments. The increase in DNB Asset Management's stake suggests the firm sees long-term growth potential in the company, which could signal positive momentum for Globus Medical's business.

The details

According to a disclosure filed with the SEC, DNB Asset Management purchased an additional 67,911 shares of Globus Medical during the third quarter, bringing its total holding to 200,918 shares. This represents about 0.15% of the medical device company's outstanding stock.

  • DNB Asset Management increased its Globus Medical stake during the 3rd quarter of 2026.

The players

DNB Asset Management AS

An investment management firm based in Norway that oversees approximately $200 billion in assets.

Globus Medical, Inc.

A medical device company specializing in musculoskeletal solutions for spine and orthopedic applications, headquartered in Audubon, Pennsylvania.

Got photos? Submit your photos here. ›

The takeaway

The increased stake by DNB Asset Management suggests the firm sees strong growth potential in Globus Medical, a leading player in the spine and orthopedics device market. This could signal positive momentum for the company as it continues to innovate and expand its product portfolio.